Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Implication of Combined Adjuvant Metformin and Aromatase Inhibitor in Overweight or Obese Postmenopausal Breast Cancer Women

NCT05053841 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.

NCT NCT05053841
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05053841 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Implication of Combined Adjuvant Metformin and Aromatase Inhibitor in Overweight or Obese Postmenopausal Breast Cancer Women
Lead sponsor
Tanta University
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2014
Completion date
June 30, 2015
Enrollment
45 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, metformin